Showing results (881-890 of 3,150) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|October 21, 2021
The Japan Society for Neuro-Oncology guideline on the diagnosis and treatment of central nervous system germ cell tumorsHideo Nakamura, Hirokazu Takami, Takaaki Yanagisawa, et al.Neuro-Oncology|March 24, 2022
TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivoShunichiro Miki, Tomoyuki Koga, Andrew M Mckinney, et al.Neuro-Oncology|February 26, 2022
Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trialsAdriana Fonseca, Cecile Faure-Conter, Matthew J Murray, et al.Neuro-Oncology|March 1, 2022
RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastomaAnn C Mladek, Huihuang Yan, Shulan Tian, et al.Neuro-Oncology|January 31, 2022
Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastomaChristine E Brown, Analiz Rodriguez, Joycelynne Palmer, et al.Neuro-Oncology|January 31, 2022
Development and validation of a deep-learning model for detecting brain metastases on 3D post-contrast MRI: a multi-center multi-reader evaluation studyShaohan Yin, Xiao Luo, Yadi Yang, et al.Neuro-Oncology|September 23, 2021
Impact of the methylation classifier and ancillary methods on CNS tumor diagnosticsZhichao Wu, Zied Abdullaev, Drew Pratt, et al.Neuro-Oncology|October 18, 2019
MRI radiomic features are associated with survival in melanoma brain metastases treated with immune checkpoint inhibitorsAnkush Bhatia, Maxwell Birger, Harini Veeraraghavan, et al.Neuro-Oncology|October 18, 2019
An independently validated survival nomogram for lower-grade gliomaHaley Gittleman, Andrew E Sloan, Jill S Barnholtz-SloanNeuro-Oncology|January 4, 2026
Epigenetic evolution of IDHwt glioblastomasBo Deng, Rania Head, Kaspar Draaisma, et al.Pageof 315